Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Nearly 1 Million Flavored Vaping Products Removed From Market, But FDA Delays Decision on Potential JUUL Ban September 10, 2021 Russell Maas Add Your Comments Federal health officials announced this week nearly one million e-cigarette products will be removed from store shelves, after applications filed by the manufacturers were rejected. Hwoever, the agency delayed a long awaited ruling on whether the highly addictive JUUL vape pods be recalled as well. The U.S. Food and Drug Administration (FDA) released an e-cigarette application update on September 9, indicating the agency has taken action on 93% of the premarket tobacco product applications (PMTAs) filed by manufacturers, covering approximately 6.5 million electronic nicotine delivery systems (ENDS) introduced over the past decade. In the release, the FDA indicated Marketing Denial Orders (MDO) have been issued for approximately 946,000 ENDS, banning nicotine products containing flavors including Apple Crumb, Dr. Cola and Cinnamon Toast Cereal, which the agency deemed a threat to attracting new teen and pre-teen tobacco users. LEARN MORE ABOUT VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As a result of growing youth nicotine addiction rates, the FDA used its oversight authority under section 910 of the Federal Food, Drug, and Cosmetic Act to claim regulatory responsibility of all Electronic Nicotine Delivery Systems (ENDS) in 2016, which includes e-cigarettes, vaping products, and all liquids used with the devices. The action classified ENDS devices as tobacco products, allowing the FDA to take control of an unregulated market, which gained national attention due to a series of problems including exploding lithium ion batteries and the illegal marketing of tobacco products targeting teens and adolescents with concealable designs and candy flavored nicotine liquids. As a result of the action, the FDA mandated that all new and existing nicotine based e-cigarette and vaping products go through premarket tobacco product applications (PMTAs). Under the new rules, manufacturers must provide evidence their vaping products benefit adult smokers enough to overcome the public health threat they represent to youth, as well as how they intended to prevent the lithium ion batteries from exploding. In July 2019, a U.S. District Court in Maryland ordered tobacco product manufacturers to submit applications to the FDA to be allowed to continue to sell any e-cigarette, cigar, pipe tobacco or hookah tobacco products which were on the market as of August 8, 2016. Those applications were originally due by May 12, 2020, but the COVID-19 pandemic resulted in that date being pushed back to September 9, 2020. No Decision on JUUL Being Removed From Market Despite the FDA’s effort to screen hundreds of PMTA’s submitted by e-cigarette manufacturers, the agency has fallen under immediate criticism for failing to render an opinion on whether to approve or reject the bestselling and highly addictive JUUL pods, which account for an estimated 40% of the e-cigarette market. “We continue to work expeditiously on the remaining applications that were submitted by the court’s Sept. 9, 2020, deadline, many of which are in the final stages of review,” Acting FDA Commissioner Janet Woodcock, M.D., and Mitch Zeller, J.D., director of the FDA’s Center for Tobacco Products, said in the press release. “For premarket tobacco product applications, our responsibility is to assess whether applicants meet the applicable statutory standard for marketing their new products.” Earlier this year in July, JUUL submitted a 125,000-page PMTA to the U.S. Food and Drug Administration (FDA). According to reports, JUUL paid $51,000 to buy the May/June issue of the American Journal of Health Behavior in order to get the journal to publish 11 studies, funded by JUUL and conducted by scientists paid by JUUL, which tout the benefits of the vaping devices in helping smokers quit. The company even shelled out an additional $6,500 to get the journal to give free access to the studies. The JUUL vape pens, which were introduced in 2015, are designed to look like USB drives, allowing teens to hide their vaping habit from parents and school officials. The pods were also sold in a variety of candy-like flavors intended to appeal to prior non-smokers, and the manufacturer targeted teens through social media and other efforts that failed to disclose the high levels of nicotine, which may cause life-long addiction problems. Currently, more than 4,500 JUUL lawsuits are being pursued against the company by individuals, school districts and municipalities, each involving similar allegations that the e-cigarette manufacturer caused a new generation of teens and young adults to become addicted to nicotine by encouraging minors or prior non-smokers to use their vaping products. JUUL is currently facing allegations claiming the manufacturer mined the middle and high school environments with easily concealable USB-like vaping products containing a highly addictive nicotine salt formulation in an effort to make life-long customers out of children. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Children, Electronic Cigarettes, Juul, Nicotine, Tobacco, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025) Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025) MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 5 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 5 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)